vs
Side-by-side financial comparison of Essent Group Ltd. (ESNT) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $312.4M, roughly 1.1× Essent Group Ltd.). Essent Group Ltd. runs the higher net margin — 49.6% vs 13.2%, a 36.4% gap on every dollar of revenue. On growth, Essent Group Ltd. posted the faster year-over-year revenue change (-0.8% vs -2.7%). Essent Group Ltd. produced more free cash flow last quarter ($848.7M vs $87.2M). Over the past eight quarters, Essent Group Ltd.'s revenue compounded faster (2.3% CAGR vs 0.4%).
Essentra PLC is a supplier of plastic and fibre products. The company operates internationally from headquarters in Kidlington, Oxfordshire. It is listed on the London Stock Exchange.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
ESNT vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $312.4M | $339.0M |
| Net Profit | $155.0M | $44.7M |
| Gross Margin | — | 59.7% |
| Operating Margin | 59.1% | 19.9% |
| Net Margin | 49.6% | 13.2% |
| Revenue YoY | -0.8% | -2.7% |
| Net Profit YoY | -7.7% | 19.3% |
| EPS (diluted) | $1.61 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $312.4M | $339.0M | ||
| Q3 25 | $311.8M | $327.3M | ||
| Q2 25 | $319.1M | $321.4M | ||
| Q1 25 | $317.6M | $330.6M | ||
| Q4 24 | $315.0M | $348.5M | ||
| Q3 24 | $316.6M | $345.5M | ||
| Q2 24 | $312.9M | $336.2M | ||
| Q1 24 | $298.4M | — |
| Q4 25 | $155.0M | $44.7M | ||
| Q3 25 | $164.2M | $38.7M | ||
| Q2 25 | $195.3M | $34.0M | ||
| Q1 25 | $175.4M | $58.0M | ||
| Q4 24 | $167.9M | $37.5M | ||
| Q3 24 | $176.2M | $33.8M | ||
| Q2 24 | $203.6M | $38.4M | ||
| Q1 24 | $181.7M | — |
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% | ||
| Q1 24 | — | — |
| Q4 25 | 59.1% | 19.9% | ||
| Q3 25 | 63.9% | 17.9% | ||
| Q2 25 | 72.4% | 16.8% | ||
| Q1 25 | 65.2% | 21.6% | ||
| Q4 24 | 61.9% | 16.9% | ||
| Q3 24 | 65.6% | 15.0% | ||
| Q2 24 | 76.4% | 11.8% | ||
| Q1 24 | 71.6% | — |
| Q4 25 | 49.6% | 13.2% | ||
| Q3 25 | 52.7% | 11.8% | ||
| Q2 25 | 61.2% | 10.6% | ||
| Q1 25 | 55.2% | 17.5% | ||
| Q4 24 | 53.3% | 10.8% | ||
| Q3 24 | 55.6% | 9.8% | ||
| Q2 24 | 65.1% | 11.4% | ||
| Q1 24 | 60.9% | — |
| Q4 25 | $1.61 | $0.95 | ||
| Q3 25 | $1.67 | $0.81 | ||
| Q2 25 | $1.93 | $0.70 | ||
| Q1 25 | $1.69 | $1.17 | ||
| Q4 24 | $1.59 | $0.74 | ||
| Q3 24 | $1.65 | $0.66 | ||
| Q2 24 | $1.91 | $0.74 | ||
| Q1 24 | $1.70 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $363.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $5.8B | $911.5M |
| Total Assets | $7.4B | $2.5B |
| Debt / EquityLower = less leverage | — | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $363.4M | ||
| Q3 25 | — | $296.4M | ||
| Q2 25 | — | $292.9M | ||
| Q1 25 | — | $306.8M | ||
| Q4 24 | — | $320.8M | ||
| Q3 24 | — | $299.3M | ||
| Q2 24 | — | $344.4M | ||
| Q1 24 | — | — |
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $5.8B | $911.5M | ||
| Q3 25 | $5.7B | $849.2M | ||
| Q2 25 | $5.7B | $882.3M | ||
| Q1 25 | $5.7B | $820.8M | ||
| Q4 24 | $5.6B | $906.9M | ||
| Q3 24 | $5.6B | $878.9M | ||
| Q2 24 | $5.4B | $905.4M | ||
| Q1 24 | $5.2B | — |
| Q4 25 | $7.4B | $2.5B | ||
| Q3 25 | $7.4B | $2.4B | ||
| Q2 25 | $7.2B | $2.5B | ||
| Q1 25 | $7.2B | $2.5B | ||
| Q4 24 | $7.1B | $2.5B | ||
| Q3 24 | $7.1B | $2.5B | ||
| Q2 24 | $6.7B | $2.5B | ||
| Q1 24 | $6.6B | — |
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $856.1M | $93.6M |
| Free Cash FlowOCF − Capex | $848.7M | $87.2M |
| FCF MarginFCF / Revenue | 271.7% | 25.7% |
| Capex IntensityCapex / Revenue | 2.4% | 1.9% |
| Cash ConversionOCF / Net Profit | 5.52× | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $1.5B | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $856.1M | $93.6M | ||
| Q3 25 | $215.9M | $111.3M | ||
| Q2 25 | $189.5M | $17.4M | ||
| Q1 25 | $221.6M | $116.6M | ||
| Q4 24 | $861.5M | $43.8M | ||
| Q3 24 | $229.2M | $48.8M | ||
| Q2 24 | $188.7M | $-27.4M | ||
| Q1 24 | $216.9M | — |
| Q4 25 | $848.7M | $87.2M | ||
| Q3 25 | $210.6M | $106.3M | ||
| Q2 25 | $188.8M | $13.6M | ||
| Q1 25 | $221.3M | $100.9M | ||
| Q4 24 | $854.8M | $35.2M | ||
| Q3 24 | $228.7M | $39.4M | ||
| Q2 24 | $187.6M | $-33.1M | ||
| Q1 24 | $212.5M | — |
| Q4 25 | 271.7% | 25.7% | ||
| Q3 25 | 67.5% | 32.5% | ||
| Q2 25 | 59.2% | 4.2% | ||
| Q1 25 | 69.7% | 30.5% | ||
| Q4 24 | 271.3% | 10.1% | ||
| Q3 24 | 72.2% | 11.4% | ||
| Q2 24 | 60.0% | -9.8% | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 2.4% | 1.9% | ||
| Q3 25 | 1.7% | 1.5% | ||
| Q2 25 | 0.2% | 1.2% | ||
| Q1 25 | 0.1% | 4.7% | ||
| Q4 24 | 2.1% | 2.5% | ||
| Q3 24 | 0.2% | 2.7% | ||
| Q2 24 | 0.3% | 1.7% | ||
| Q1 24 | 1.5% | — |
| Q4 25 | 5.52× | 2.09× | ||
| Q3 25 | 1.31× | 2.88× | ||
| Q2 25 | 0.97× | 0.51× | ||
| Q1 25 | 1.26× | 2.01× | ||
| Q4 24 | 5.13× | 1.17× | ||
| Q3 24 | 1.30× | 1.44× | ||
| Q2 24 | 0.93× | -0.71× | ||
| Q1 24 | 1.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESNT
| Mortgage Insurance Segment | $192.4M | 62% |
| Other | $120.0M | 38% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
